chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have been a diabetic for 52 years.  I got the second shot of the Pfizer COVID vaccine in February 2021 and shortly after that I started noticing the my blood sugar levels would stay low for long periods of time even though my food intake was way over my normal amounts.  This went on for 2 or 3 weeks,  Then the low blood sugar levels would become sporadic.  After I got the 3rd shot ( Booster ) on 10/07/2021, the low blood sugars started up again.  For the last three weeks I can't get my blood sugar levels to stay high enough for me to do any activities, even though I have reduced my insulin intake a lot .  This is causing severe anxiety.    I have no way to prove this is the cause.  Two other notes; I got the flu shot on 09/24/2021 and started experiencing diariah .  My doctor gave me a prescription for Ciprofloxacin 500mg to b e taken twice a day for 5 days 0n 10/11/2021.  The next day my blood sugar levels went low.  Can you look into this?  I don't know if there is any and effect.
Began day after shot - fever over 100, chills, headache, nausea, body aches, joint pain.  Lasted for 2 days.  Arm swelling and pain lasted 5 days.  Nausea upon eating and occasional diarrhea still ongoing.  About 2 weeks later developed dermatitis (itchy rash) on face - eyelids, sides of nose, corners of mouth, chin, swollen glands, sore throat.  Ongoing.
Received HPV 3-12-10 @ 1600 L delt. Noted macular papular rash after noon 3-15-10 on L delt. Pt instructed by PAC to take ZYRTEC 10 mg once daily.
Information has been received from a physician concerning a 7 yr old white female who, at 12 months of age, on 20Jan99, was vaccinated with a SC 0.5ml dose in the left thigh of varicella virus vaccine live (lot624060/1417E). It was reported that the pt developed breakthrough chickenpox with over 200 lesions. It was noted that the pt may have had lesions in her mouth. Unspecified medical attention was sought. No product quality complaint was involved. Follow up information from a health professional indicated that on 13May05 the pt's presented to the office with chickenpox that began on 11May05. It was reported that the pt recovered on 20May05. The pt's vaccination history included the following: a first, second, and third dose in upper left thigh of diphtheria toxoid (+) pertussis acellular Biken vaccine (+) tetanus toxoid (Tripedia) (lot748150, 0907380, and 093977) on 26Feb98, 06May98, and 24Jul98 respectively, a first dose in the right thigh of diphtheria toxoid (+) pertussis acellular 3 component vaccine (+) tetanus toxoid (Infanrix) (lot 862A2) on 09Apr99, a first and second dose of poliovirus vaccine inactivated (Ipol) (lotM0939 and M1294) on 26Feb98 and 06Aug98 respectively, a first oral dose of poliovirus vaccine live oral (Orimune) (lot 455652) on 19Oct98, a first dose in the left thigh of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot628549/1182H) on 09apr99, a first and second in upper right thigh, and a third dose in the lower left thigh of Hib conj vaccine (Tet toxoid) (ACTHIB) (lot70919184, 0907880, and 09047380) on 26feb98, 06May98, and 22Jul98 respectively, a first dose in the right lower thigh of Hib conj vaccine (crm197) (Hibtiter) (lot 402253A) on 09Apr99, a first dose in the lower right thigh of hep B virus vaccine rHBsAg (yeast) (lot 622702/0198E) on 26Feb98, a first dose of hep B virus vaccine rHBsAg (yeast) (Engerix B) (lot ENG241842) on 06May98, and a second dose of hep B virus vaccine rHBsAg (yeast) (lot 625404/1497E) on 19Oct98. Additional information is not expected.
Axillary  cording  right and left arm pain  left face numbness left and right chest and shoulder pay
09/10/2021 2:30pm hives/rash and swelling of hands and feet took OTC Benadryl  09/10/2021 8:00pm swelling of ears, eyes, and lips began took more OTC Benadryl  09/11/2021 8:30am eyes swollen almost shut, lips swollen, face, neck, and ears, hands and feet swollen rash/hives went to ER they pushed IV Benadryl, Pepcid, and steroids and fluids and advised taking Benadryl and Pepcid otc to treat symptoms  09/13/2021 still treating hives and swelling for he gave
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 89 year-old female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Lot number: EN6205) as dose 2, single and administration date 02Feb2021 (Lot number: EL9266) as dose 1, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (medically significant), outcome "unknown", described as "heart trouble"; HYPOACUSIS (non-serious), outcome "unknown", described as "Hard of hearing". Additional information: Patient took dose 2 at local hospital and dose 1 was at local pharmacy. Patient stated that she was 89 year old and has heart trouble. She was hard of hearing and is having trouble. She mentioned something about her cardiac doctor but does not provide further details. No follow-up attempts are possible. No further information is expected.
Information has been received from a physician who reported that her mother was talking with her friend, a 70 year old patient who was vaccinated with a dose of zoster vaccine live (Oka/Merck). Subsequently the patient experienced a rash. At the time of the report, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information has been requested.
pt told her dad that she was not feeling well and lost consciousness and had seizure for about 5 seconds.  vitals monitored, WNL.  Pt A&Ox4, observed for additional 30 minutes while constantly monitoring vitals, stated she felt better and was driven home by her dad.
Chills and shivering started about 10 PM, lasting 45 minutes.  Nausea. Temp of 101.6. General malaise. Overall body aches, headache. These lasted all night. Nausea, headaches, body aches and general malaise persisting today (10/18/2019) No treatments other than trying to get warm, even with high temp
Patient was given 0.25mcg of Moderna Bivalent Booster but was to be given 0.5mcg, wrong dosage given
fasciculations at her left shoulder/The next day she was having fasciculations and all of her extremities as well as feeling fasciculations in glutes and left abdomen.; she started developing soreness at injection site; With the fasciculations, sometimes she experiences a pain which she characterizes as under her skin and sharp however fasciculations are sometimes not accompanied by pain.; This is a spontaneous report from a contactable Physician. A 14-year-old female patient (Pregnant: No) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), the first dose via intramuscular in left arm on 09Jul2021 and the second dose via unspecified route of administration on an unspecified date in 2021, both as single dose for COVID-19 immunization. The relevant medical history included seasonal allergies from unspecified date. Concomitant medications were not reported. On 09Jul2021 patient had first COVID Pfizer vaccine in left arm. During the day, she started developing soreness at injection site, and then started noticing fasciculations at her left shoulder. The next day she was having fasciculations and all of her extremities as well as feeling fasciculations in glutes and left abdomen. With the fasciculations, sometimes she experienced a pain which she characterized as under her skin and sharp however fasciculations were sometimes not accompanied by pain. She had her second Pfizer vaccine without worsening of her symptoms. The symptoms did continue and would happen multiple times per day. She would herself and noticed these while sitting at school, or when trying to fall asleep. Towards the end of July, she was given a 5-day course of muscle relaxants which significantly alleviated her symptoms. After this, she primarily only had symptoms in her legs, and only occasionally will had symptoms in the glutes, left side of her abdomen, L shoulder. The adverse event result in Doctor or other healthcare professional office/clinic visit. Treatment received for the events included muscle relaxants. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the limited information a contributory effect of the vaccine BNT162B2 to the reported event Fasiculation cannot be ruled out.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
had site common effect with Shingrix first dose; This case was reported by a physician via call center representative and described the occurrence of injection site reaction in a female patient who received Herpes zoster (Shingrix) (batch number 5816082903 ?, expiry date unknown) for prophylaxis.   Concurrent medical conditions included guillain barre syndrome.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site reaction. On an unknown date, the outcome of the injection site reaction was recovered/resolved.   It was unknown if the reporter considered the injection site reaction to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient mentioned that she also had site common effect with Shingrix first dose but nothing happened. On 18th March 2021, the patient would receive Covid vaccine at physician's office but they were afraid of this shot because they did not know the causality of Shingrix side effects.  The reporter consented to follow up. For tolerance of 2nd dose, refer case US2021062740.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021062740:same patient, same reporter
devel a very mild case of varicella & occipital h/a w/only about a dozen lesions;no fever;only few days of illness;unvaccinated cousin contact had much more of a typical case;had onset of sx the same day;
One hour after vaccination, infant developed angioedema of eyelids and lips which resolved with treatment with in 24 hours. After 24 hours, infant developed a rash and became labile with poor feeding.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On 01-SEP-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 injection, lot # M021407, expiry date 30-APR-2018 (dose, route of administration and anatomical location were not specified). The administered dose of GARDASIL 9 was stored at 33.4 Fahrenheit degrees for 52 minutes. There was no previous temperature excursion. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
bumps under her skin/hives on the left arm, up and down not just around the injection site with red spots. Then there were some that developed on the right arm; red spots; This is a spontaneous report from a contactable consumer (Patient) via Medical Information Team. A 72-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Lot# unknown), on 25Mar2021 and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Lot# unknown), on 15Apr2021, both via an unspecified route of administration as a single dose for COVID-19 immunization. On 19Apr2021 or 20Apr2021, patient developed bumps under her skin or hives on the left arm, up and down, not just around the injection site with red spots. There were some that developed on the right arm but not as much. Patient wanted to know whether these were the side effects of the vaccine. The outcome of the events was unknown.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Immediate intense pain at the time of the injection. The pain instantly spread from the injection site throughout left arm down to fingertips. Very limited arm movement since the time of injection (11 weeks ago). Arm aches while at rest, but the pain greatly intensifies and is severe when arm is in motion. Decreased range of motion of left shoulder. Decreased strength in left arm. Excruciatingly painful to lift anything with left arm. Numbness and tingling in fingers of left hand.
Probably the second day after having the shot, my resting pulse was slightly elevated 100-135. The Tachycardia disappeared after about 3 days but then I started to get more increasing cases of the Tachycardia pauses. By the 2nd week for the entire week, I would go into Tachycardia then Bradycardia to the point of passing out. I've never experienced Bradycardia before. That was a significant change. And that would happen every 15-20 minutes for the week. And then it would happen less to about every hour, it would happen more frequently when it was happening in the beginning portion. It would happen very quickly then it would end. Period of lightheadedness would be much longer. My ECG would show that periods of pause would happen for 1-2 seconds. As time progressed, they became longer with pauses before a beat. And there would a string of them together. It culminated with multiple pauses about 2 ½ - 2 ¾ seconds and strung together for about 13 seconds. It finally culminated with implanting a pacemaker. Since the surgery, there have been minor pauses, still adjusting.
Immediately after patient had MENACTRA, she suffered syncope, fell off table, had brief seizure after she fell onto her face. Patient diagnosed with syncope, brief convulsive seizure, facial contusion, concussion.
Headache; upper GI cramping; diarrhea; This is a spontaneous report from a contactable consumer. This 61-Years-Old female (Patient) reported that,  A 61-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EY0584) (at the age of 61 years old), dose 1 via an unspecified route of administration, administered in arm right on 07Jul2021 23:00 as dose 1, single for covid-19 immunisation. Medical history included seasonal allergy from an unknown date and unknown if ongoing Seasonal allergies and migraines, migraine from an unknown date and unknown if ongoing Seasonal allergies and migraines. Concomitant medication(s) included amitriptyline (AMITRIPTYLINE) taken for an unspecified indication, start and stop date were not reported; clonazepam (KLONOPIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took midrin [dichloralphenazone; isometheptene mucate; paracetamol] for drug hypersensitivity. It was reported that on 22Jul2021 10:00, patient experienced upper GI cramping at twelve hours and bad cramps with diarrhea 24 hours after injection which became severe for seven days which she treated with Imodium on day six and seven. She still had cramping and diarrhea. Patient did not have covid prior to vaccination. Patient was not tested for covid post vaccination. The outcome of the events was not recovered.  Follow-Up (24Aug2021): Follow-up attempts are completed. No further information is expected.
Pt received flu vaccine on 3NOV13 in the left arm. After administering vaccine, pt's left arm became swollen and bleeding. 5 minutes after, I applied pressure to the area and applied an ice pack to lower the swelling.
This was his 1st dose of Moderna, but his booster dose.  He received Janssen in April 2021.  Patient began experiencing double vision approximately 7-8 hours after receiving the vaccine
This spontaneous report as received from a certified medical assistant refers to a 4 year old patient of an unknown gender. The patient's pertinent medical history, drug reactions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with VARIVAX (Merck) unknown route and strength (lot # K015970 with expiration date 23-SEP-2016 or lot # K021847 with expiration date 03-NOV-2016 or lot # L001335 with expiration date of 13-JAN-2017) which were exposed to temperatures outside of the recommended range. There was no adverse event reported. The reporter could not break out which specific lot number of vaccine was administered to the patient. This is one of the several reports received from the same reporter. Additional information has been requested.
Full case of Varicella per parents reliable history with healed crusted lesions over entire body on exam 13d after administration, lesions particularly centered at administration site.  Purely subjectively but clinic seems to have a recently increased incidence of (usually local) side effects from Varivax of same lot number (though several lots currently in use in clinic) supplied by state.  I am physician MD, partner of administering physician, who saw patient in follow-up.
kids, ages 16 and 17 received the Moderna vaccine on April 1st; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (kids, ages 16 and 17 received the Moderna vaccine on April 1st) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (kids, ages 16 and 17 received the Moderna vaccine on April 1st). On 01-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (kids, ages 16 and 17 received the Moderna vaccine on April 1st) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.   This case was linked to MOD-2021-207480 (Patient Link).
No adverse effects reported; a dose of VAQTA, which expired on 07-JUL-2020, and was inadvertently administered on 06-AUG-2020; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and drug allergies or reactions were not reported.   On 06-AUG-2020, the patient was inadvertently vaccinated with an expired vaccine of hepatitis a vaccine, inactivated (VAQTA) prefilled syringe, one dosage form as prophylaxis; lot number S012250 with an expiration date on 07-JUL-2020 (expired product administrated) (strength, anatomical location and route of administration were not provided). No adverse effects reported, nor product quality complain involved. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S012250; expirationdate: 07-JUL-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
mom took pt to ER 1AM on 13JAN95 w/ c/o rash on face & blotches on back; some fever doesn't know how much; said ER doesn't know if related to vax or not;
No other illness, patient had already completed the 2 dose moderna series previous.  Recieved 1 dose of pfizer accidentally instead of a flu shot.   no adverse affects reported within the 15 minute time frame.
Atrial fibrillation occurred about 11 hours after administration of vaccine. Lasted about 8 hours. NSR the next 20 hours, then another bout of Afib for about 5 hours, then NSR for another 20 hours or so, then Afib again for another 9 hours. Now in NSR and 55 hour post-administration. I have paroxysmal non-valvular Afib, but the current onset is very atypical, in fact unique, in that I normally have a brief episode about once a month.
A lot of fatigue; Shoulder pain; Neck pain; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient received bnt162b2 (BNT162B2), administration date 02Dec2021 (Lot number: FH8028) at the age of 63 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (1st dose, Manufacturer- Unknown), when the patient was 63 years old, for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious) with onset Dec2021, outcome "recovered" (14Dec2021), described as "A lot of fatigue"; ARTHRALGIA (non-serious) with onset Dec2021, outcome "recovered" (14Dec2021), described as "Shoulder pain"; NECK PAIN (non-serious) with onset Dec2021, outcome "recovered" (14Dec2021), described as "Neck pain"; HEADACHE (non-serious) with onset Dec2021, outcome "recovered" (14Dec2021), described as "Headache".  Additional information: It was really more from the second injection (Incomplete sentence). The side effects especially from the 2nd injection which the patient had 02Dec, the patient had a lot of fatigue and had shoulder and neck pain and headache for almost 2 weeks. Date of adverse event started: the patient stated, "It would have been around the 02Dec or 03Dec to 14Dec2021."   Follow-Up (11Jan2022): Follow-up attempts are completed. No further information is expected.
Developed rash & pruritus on neck w/ external swelling. Swelling & rash became worse, developed headache & neck pain. Took benadryl then saw MD. Started prednisone & hydrocortisone cream on 2/1/21.
The patient presents with sinus congestion, cough, and fever. Her husband tested positive for COVID on Wednesday and she has had close contact. She is fully vaccinated with booster shot received three days ago. Symptoms began with congestion yesterday, fever/chills developed last night. starting 11/24/21
Patient contracted COVID after being fully vaccinated.  No booster. Body Aches, Fever, cough, fatigue, abdominal pain, loss of taste and smell. Received monoclonal antibodies (Regeneron) on 11/16/2021
Patient fainted and fell to the floor within 15 minutes of vaccination.  He was observed to have seizure-like activity for approximately 20 seconds.  Patient was transported to ER by EMS.